Evidence map›Paper›PMID 27788212›Full record

ArticlePloS one2016

EGF Functionalized Polymer-Coated Gold Nanoparticles Promote EGF Photostability and EGFR Internalization for Photothermal Therapy.

Catarina Oliveira Silva, Steffen B Petersen, Catarina Pinto Reis, Patrícia Rijo, Jesús Molpeceres, Ana Sofia Fernandes, Odete Gonçalves, Andreia C Gomes, Isabel Correia, Henrik Vorum and 1 more

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
1.5field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 43 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Review
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Review
  17. Review
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 6 institutions in 3 countries.

Catarina Oliveira SilvaResearch Center for Biosciences & Health Technologies, Universidade Lusófona, Lisboa, Portugal.
Steffen B PetersenMedical Photonics Lab, Department of Health Science and Technology, Faculty of Medicine, Aalborg University, Aalborg, Denmark.
Catarina Pinto ReisResearch Center for Biosciences & Health Technologies, Universidade Lusófona, Lisboa, Portugal.
Patrícia RijoResearch Center for Biosciences & Health Technologies, Universidade Lusófona, Lisboa, Portugal.
Jesús MolpeceresDepartment of Biomedical Sciences, Faculty of Pharmacy, University of Alcalá, Alcalá de Henares, Spain.
Ana Sofia FernandesResearch Center for Biosciences & Health Technologies, Universidade Lusófona, Lisboa, Portugal.
Odete GonçalvesMedical Photonics Lab, Department of Health Science and Technology, Faculty of Medicine, Aalborg University, Aalborg, Denmark.
Andreia C GomesCBMA (Centre of Molecular and Environmental Biology), University of Minho, Campus de Gualtar, Braga, Portugal.
Isabel CorreiaCentro de Química Estrutural, Instituto Superior Técnico, Universidade de Lisboa, Lisbon, Portugal.
Henrik VorumDepartment of Ophthalmology, Aalborg University Hospital, Aalborg, Denmark.
Maria Teresa Neves-PetersenDepartment of Clinical Medicine, Aalborg University Hospital, Aalborg, Denmark.
Universidade Lusófona · PTAalborg University Hospital · DKUniversity of Lisbon · PTUniversity of Minho · PTAalborg University · DKUniversidad de Alcalá · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The application of functionalized nanocarriers on photothermal therapy for cancer ablation has wide interest. The success of this application depends on the therapeutic efficiency and biocompatibility of the system, but also on the stability and biorecognition of the conjugated protein. This study aims at investigating the hypothesis that EGF functionalized polymer-coated gold nanoparticles promote EGF photostability and EGFR internalization, making these conjugated particles suitable for photothermal therapy. The conjugated gold nanoparticles (100-200 nm) showed a plasmon absorption band located within the near-infrared range (650-900 nm), optimal for photothermal therapy applications. The effects of temperature, of polymer-coated gold nanoparticles and of UVB light (295nm) on the fluorescence properties of EGF have been investigated with steady-state and time-resolved fluorescence spectroscopy. The fluorescence properties of EGF, including the formation of Trp and Tyr photoproducts, is modulated by temperature and by the intensity of the excitation light. The presence of polymeric-coated gold nanoparticles reduced or even avoided the formation of Trp and Tyr photoproducts when EGF is exposed to UVB light, protecting this way the structure and function of EGF. Cytotoxicity studies of conjugated nanoparticles carried out in normal-like human keratinocytes showed small, concentration dependent decreases in cell viability (0-25%). Moreover, conjugated nanoparticles could activate and induce the internalization of overexpressed Epidermal Growth Factor Receptor in human lung carcinoma cells. In conclusion, the gold nanoparticles conjugated with Epidermal Growth Factor and coated with biopolymers developed in this work, show a potential application for near infrared photothermal therapy, which may efficiently destroy solid tumours, reducing the damage of the healthy tissue.

Indexed as

PhototherapyA549 CellsCell SurvivalDrug CarriersEpidermal Growth FactorErbB ReceptorsGoldHumansHyaluronic AcidLightMetal NanoparticlesOleic AcidPolymersProtein StabilityProtein TransportTemperatureDrug CarriersEpidermal Growth FactorErbB ReceptorsGoldHyaluronic AcidOleic AcidPolymers

Identifiers

PMID27788212
PMCPMC5082958
OpenAlexW2540439321

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.